OMA1 and glomerulosclerosis: Our findings demonstrate that genetic Oma1 ablation rescues glomerular disease phenotypes in podocyte-specific Phb2ko mice, resulting in improvements in lifespan, renal function, glomerulosclerosis, podocyte count, slit diaphragm length, slit diaphragm organization, as well as mitochondrial morphology.